SCM
ABEO icon

Suvretta Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Suvretta Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12M Hold
2,676,000
– – 0.31% 47
2025
Q4 		$14.1M Hold
2,676,000
– – 0.29% 59
2025
Q3 		$14.1M Hold
2,676,000
– – 0.36% 59
2025
Q2 		$15.2M Sell
2,676,000
-1,009,503
-27% -$5.75M 0.46% 50
2025
Q1 		$17.5M Hold
3,685,503
– – 0.65% 41
2024
Q4 		$20.5M Hold
3,685,503
– – 0.7% 44
2024
Q3 		$23.3M Hold
3,685,503
– – 0.75% 44
2024
Q2 		$15.6M Buy
+3,685,503
New +$18.8M 0.57% 44

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Suvretta Capital Management's ABEO Position: Q1 2026 in Review

Suvretta Capital Management held its Abeona Therapeutics (ABEO) position steady in Q1 2026 at 2,676,000 shares worth $12M. The position accounts for 0.31% of the portfolio, ranked #47.

Suvretta Capital Management first reported a position in ABEO in Q2 2024 and has held it in 8 quarters since. The position peaked at $23.3M in Q3 2024. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Suvretta Capital Management held 2,676,000 shares of Abeona Therapeutics worth $12M as of Q1 2026.
  • Suvretta Capital Management left its Abeona Therapeutics share count unchanged in Q1 2026.
  • Abeona Therapeutics made up 0.31% of Suvretta Capital Management's portfolio in Q1 2026, its #47 holding.
  • Suvretta Capital Management first reported a position in Abeona Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Suvretta Capital Management's Abeona Therapeutics position peaked at $23.3M in Q3 2024.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.